What Morcher does

Morcher GmbH is a privately held, family-owned German medical device manufacturer founded in 1948 in Stuttgart, specializing in ophthalmic surgical implants. The company develops, produces, and sells intraocular lenses (IOLs), capsular tension rings (CTRs), aniridia implants, and accessory products used in cataract surgery and related ophthalmic procedures, with materials spanning PMMA, hydrophilic acrylic, and a proprietary hydrophobic acrylic (LOTUS). Its product portfolio includes multiple CTR variants (standard Types 14/14C/14A/13A/13B/10C, preloaded EyeJet for 2.2mm incision, Cionni scleral-fixation models, and 120° Capsular Segments), foldable IOLs across hydrophilic and hydrophobic platforms, PMMA IOLs for short eyes, Caliper Rings for capsulorhexis precision, the patented Bag-In-the-Lens (BIL) technique co-developed with Prof. Dr. Tassignon, and the first aniridia IOL with iris-diaphragm co-developed with Prof. Sundmacher. A patented gamma sterilization method (introduced 1981) underpins the manufacturing process, and regulatory coverage includes CE certification (1994, one of the first IOL manufacturers) and FDA approval for capsular tension rings (2003).

The company operates a direct B2B sales motion targeting ophthalmic surgeons, hospitals, and eye clinics across DACH, broader Europe, and the United States, with no disclosed distributor or reseller channel. Commercial engagement is supported by multilingual website content, a surgical technique video library, downloadable catalogs and IFUs, customer service (Mon-Thu 8:00-16:30 CET, Fri 8:00-16:00 CET), and participation in international ophthalmic congresses including ESCRS. Revenue is generated through one-time medical device sales of implants and, as a complementary business unit, through custom/OEM development services (consulting, prototyping, tool-manufacturing, raw materials sourcing, and full production) for medical device partners. Pricing is quote-based and not publicly disclosed. The company employs between 11 and 50 people, is led by Managing Director Olaf Kurt Morcher (CEO since 1989, second-generation leadership), and maintains owner-managed decision-making with no external institutional investment, parent company, or subsidiaries identified in the source data.

Name

Morcher

Legal name

Morcher GmbH

Website

https://morcher.com

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

11–50 employees

Short description

Morcher GmbH is a family-owned German manufacturer, founded 1948, of ophthalmic surgical implants including intraocular lenses, capsular tension rings, aniridia implants, and the Bag-In-the-Lens system, serving ophthalmic surgeons and eye clinics worldwide.

Ownership category

akta.pro rank

Product category

Ophthalmic Implants and Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH)

Keywords

• Ophthalmic implants
• Intraocular lenses
• Capsular tension rings
• Cataract surgery devices
• Medical eye surgery

Headquarters

HQ city

Stuttgart

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Others

Revenue model

1. Medical Device Sales: Sale of ophthalmic implants including intraocular lenses, capsular tension rings, and accessory products to hospitals, ophthalmic surgeons, and clinics worldwide.
2. Custom/ OEM Manufacturing: Custom development and manufacturing services for eye implants including consulting, development, construction, prototyping, and OEM manufacturing for partners.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Morcher GmbH manufactures and sells ophthalmic implants for medical eye surgery, with a core focus on intraocular lenses (IOLs) for cataract operations, capsular tension rings (CTRs) and related devices for zonular support, aniridia implants with iris-diaphragm, specialty implants for short eyes, and the patented Bag-In-The-Lens system. The company supplements its manufactured product line with custom and OEM Development Services covering consulting, prototyping, tool-manufacturing, raw material sourcing, and full production for eye-implant partners. Customers are hospitals, ophthalmic surgeons, and eye clinics served through direct enterprise sales, supported by proprietary technologies such as BIL, patented gamma sterilization, LOTUS hydrophobic material, and EyeJet preloaded CTR delivery.

Product overview

Morcher GmbH is a manufacturer of ophthalmic implants comprising multiple interconnected product lines. The core portfolio centers on Capsular Tension Rings (CTRs) in standard and preloaded EyeJet formats, and Intraocular Lenses (IOLs) available in hydrophilic and PMMA materials. These are complemented by Cionini Rings for scleral fixation, Capsular Segments for extensive zonular loss, Caliper Rings for surgical precision, Aniridia Implants with iris diaphragm, Pupil Dilators, and the patented Bag-In-The-Lens system. The company also offers Development Services for custom OEM implant design and manufacturing. The products serve cataract surgery, aniridia correction, and various zonular support applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Capsular Tension Rings (CTRs) PMMA open-ring devices with blunt-tipped eyelets designed to stabilize weakened, broken, or missing zonules and prevent IOL decentration after capsular shrinkage, available in multiple models (Types 14, 14C, 14A, 13A, 13B, 10C) with various sizes and features for ophthalmic surgeons performing cataract surgery.
• EyeJet Preloaded Capsular Tension Rings Preloaded capsular tension rings delivered via injector system through a 2.2 mm incision, available in right (clockwise) and left (counter-clockwise) directional variants for Types 14, 14C, 14A, 13A, and 13B, enabling controlled implantation for cataract surgeons.
• Cionni Rings for Scleral Fixation CTRs with additional fixation eyelets that allow permanent scleral fixation with sutures, including models 1G, 1L, 2C, 2L, 2S, 10G, and 10L for various zonular weakness scenarios in anterior segment surgery.
• Capsular Segments for Scleral Fixation Partial PMMA ring segments tracing a 120° arc for patients with extensive or progressive zonular loss; models 6D and 6E provide support in fixation areas without generating 360° expansile force.
• Hydrophilic Intraocular Lenses (IOLs) Foldable hydrophilic acrylic intraocular lenses including models 92S, 46G, 90L, 92G, 92B, 92C, 97B, 90S, and 89F for cataract surgery, featuring various diopter ranges, haptic designs, and hydrophilic acrylic material with 28% water content.
• PMMA IOLs for Short Eyes Intraocular lenses specifically designed for short eyes (<18.0mm) and/or small white-to-white measurements <10.0mm, including models 89A and 89D with hydrophilic acrylic material for pediatric and short-eye cataract surgery patients.
• Caliper Rings Temporary surgical devices enabling precise anterior capsulorhexis creation, available in models 4, 4L, 5, 6, and 76E with various total diameters and capsulorhexis inner diameters for surgeons requiring precise capsulorhexis sizing.
• Aniridia Implant IOL with iris diaphragm for intraocular correction of congenital and acquired aniridia, developed with Prof. Sundmacher, addressing full or partial iris defects in anterior segment surgery.
• Pupil Dilator Accessory device used in patients with constricted pupils to expand the pupil opening during cataract or anterior segment surgery.
• Bag-In-The-Lens (BIL) IOL Intraocular lens designed and patented to prevent secondary opacification, developed with Prof. Dr. Tassignon as the Bag-In-the-Lens technique for cataract surgery.
• Development Services (OEM and Custom Implant) Comprehensive OEM and custom implant development services for eye implants, including consulting, development, construction, prototyping, tool-manufacturing, raw materials sourcing, and full production capabilities for medical device partners.

Quantifiable outcome

• Over 650,000 cataract surgeries performed annually in Germany alone demonstrate the scale of the addressable market for MORCHER products

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Prof. Dr. TassignoncoreStrategic or Co-development Partner · 1 January 1998Development and patenting of Bag-In-the-Lens (BIL) technology with Prof. Dr. Tassignon for preventing secondary opacification in cataract surgery.
• Dr. Nishi / Dr. MenapaceminorStrategic or Co-development Partner · 1 January 1996Development of first capsular edge ring according to Nishi/Menapace in 1996, introducing Sharp Edge Design to inhibit posterior capsule opacification.
• Prof. SundmachercoreStrategic or Co-development Partner · 1 January 1990Development of first Aniridia-IOL with Iris-diaphragm together with Prof. Sundmacher for intraocular correction of congenital and acquired aniridia.
• Dr. PayerminorStrategic or Co-development Partner · 1 January 1990Development of first pseudo-accommodating IOL by Dr. Payer with zoom effect for pseudo-accommodation.
• Dr. C. D. BinkhorstcoreStrategic or Co-development Partner · 1 January 1958Collaboration with Dutch ophthalmologist Dr. C. D. Binkhorst to develop the Iris-Clip-Lens in 1958, marking the beginning of micro-surgery with intraocular lens implantation.
• Dr. H. DannheimcoreStrategic or Co-development Partner · 1 January 1955Collaboration with Dr. H. Dannheim in 1955 to develop the first anterior chamber lens (Dannheim lens), marking the beginning of MORCHER's leadership in intraocular lens development.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• STAAR Surgical: Specialist IOL company known for the Visian ICL (phakic IOL) and EVO family. Overlaps with Morcher in premium and specialty IOLs though focuses more on refractive phakic lenses than cataract implants.
• HumanOptics: Germany-based specialist manufacturer of intraocular lenses and iris implants, including custom IOLs. Most directly comparable German competitor to Morcher in specialty IOLs and iris reconstruction implants.
• EyeKon Medical: Specialist ophthalmic implant manufacturer offering foldable IOLs and capsular tension rings, directly overlapping Morcher's core catalog of IOLs and CTRs.
• HOYA Corporation (Surgical Optics): Japanese-headquartered IOL manufacturer competing with Morcher in standard and premium IOL categories for cataract surgery. Similar specialty positioning, larger global footprint.
• Rayner Intraocular Lenses: UK-based specialist IOL manufacturer with a broad portfolio of hydrophilic and hydrophobic IOLs. Direct competitor in the same specialty IOL space as Morcher, with similar size and channel model.

Broad incumbents

• Bausch + Lomb: Broad ophthalmic surgical portfolio including IOLs (e.g., enVista, Akreos) competing with Morcher's IOL product line. Larger platform player with broader product breadth.
• Alcon: Global leader in ophthalmic surgery including IOLs and cataract surgical devices. Directly competes with Morcher across standard IOL categories and dwarfs the company in scale, but does not specialize in niche capsular tension rings and complex implants.
• Carl Zeiss Meditec: German-headquartered ophthalmic diagnostics and surgical technology company. Adjacent in surgical ophthalmology with visualization and biometry that pairs with IOL implantation; overlaps with Morcher in cataract surgical workflow.
• Johnson & Johnson Vision (Tecnis): Major multinational IOL manufacturer with the Tecnis portfolio, competing in cataract surgery IOLs. Overlaps with Morcher's standard IOL lines but does not focus on specialty capsular and aniridia implants.

Emerging players

• Kowa Company (Ophthalmics): Japanese specialty IOL manufacturer with a focused cataract surgery portfolio. Comparable in size and product range to Morcher, with growing presence in European markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/689132091259737

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Morcher